Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer - Giacchetti,S.; Perpoint,B.; Zidani,R. (J Clin Oncol, 2000)